You are on page 1of 3

Global Human Insulin Market $34.

4 Billion by 2021

According to a market research report Human Insulin Market Analysis and Forecast 2017-2021 published by
iHealthcareAnalyst, Inc., the global human insulin market is estimated to reach $34.4 Billion in 2021, expanding at
a CAGR of 4.8% from 2017 to 2021.

The human insulin market report estimates the market size (Revenue $million - 2014 to 2021) and composition of
this market in terms of five product classes such as slow-acting, fast-acting, long-acting, intermediate-acting and
premixed insulin and forecasts growth trends (CAGR% - 2017 to 2021). It also covers the major competitors operating
in the market and provides a birds eye view of the different insulin analogs available in the global market.

The global human insulin market research report is divided by geography (regional and country based) into North
America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest
of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Visit the Human Insulin Market Analysis and Forecast 2017-2021 report at

1. Source
1.1. Human
1.2. Recombinant

2. Mode of Action
2.1. Slow-Acting (Basal) Analogs
2.2. Fast-Acting Analogs
2.2.1. Pipeline Analysis Afrezza NN1218 (FIAsp)
2.3. Long-Acting Analogs
2.3.1. Pipeline Analysis IDegLira (Xultophy) LY2605541(Novel Basal Insulin Analog) LY2963016 (Long Acting Basal Insulin) MK-1293 (Sustained Release Insulin Analog) U-300 (Toujeo)
2.4. Intermediate-Acting Analogs
2.5. Premixed Insulin

3. Company Profiles
3.1. Eli Lilly and Company
3.2. Novo Nordisk A/S
3.3. Sanofi
3.4. Thermalin Diabetes, LLC

To request Table of Contents and Sample Pages of this report visit:

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis,
and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting
grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics,
healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view
of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States